Subscribe

What are you looking for?

Main Menu

明報新聞網

中國生物製藥加強與GSK合作 推兩款呼吸領域創新藥物

Future Wealths
Future Wealths
8 7 月, 2026
One Min Read
1 Views
0 Comments
中國生物製藥（1177）宣布，其附屬公司正大天晴藥業進一步加強與葛蘭素史克（GSK）於5月份達成的獨家戰略合作，推動兩款呼吸領域重磅創新藥物惠及更多中國患者。

原文: https://finance.mingpao.com/fin/instantf/20260708/1783498812329/%E4%B8%AD%E5%9C%8B%E7%94%9F%E7%89%A9%E8%A3%BD%E8%97%A5%E5%8A%A0%E5%BC%B7%E8%88%87gsk%E5%90%88%E4%BD%9C-%E6%8E%A8%E5%85%A9%E6%AC%BE%E5%91%BC%E5%90%B8%E9%A0%98%E5%9F%9F%E5%89%B5%E6%96%B0%E8%97%A5%E7%89%A9%22%20target=%22blank

Last Update: 8 7 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept